TY - JOUR T1 - Undocumented infectives in the Covid-19 pandemic JF - medRxiv DO - 10.1101/2020.07.09.20149682 SP - 2020.07.09.20149682 AU - Maurizio Melis AU - Roberto Littera Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/07/11/2020.07.09.20149682.abstract N2 - Background A crucial role in epidemics is played by the number of undetected infective individuals who continue to circulate and spread the disease. Epidemiological investigations and mathematical models have revealed that the rapid diffusion of Covid-19 can mostly be attributed to the large percentage of undocumented infective individuals who escape testing.Methods The dynamics of an infection can be described by the SIR model, which divides the population into susceptible (S), infective (I) and removed (R) subjects. In particular, we exploited the Kermack and McKendrick epidemic model which can be applied when the population is much larger than the fraction of infected subjects.Results We proved that the fraction of undocumented infectives, in comparison to the total number of infected subjects, is given by where R0 is the basic reproduction number. Its mean value R0 = 2.10 (2.09 − 2.11) in three Italian regions for the Covid-19 epidemic yielded a percentage of undetected infectives of 52.4% (52.2% - 52.6%) compared to the total number of infectives.Conclusions Our results, straightforwardly obtained from the SIR model, highlight the role played by undetected carriers in the transmission and spread of the SARS-CoV-2 infection. Such evidence strongly recommends careful monitoring of the infective population and ongoing adjustment of preventive measures for disease control until a vaccine becomes available.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThis study is not a clinical trial.Funding StatementThe authors received no specific funding for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No IRB and/or ethics committee approvals have been necessary for this study.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the data about Covid-19 epidemic in Italy are available from the database of the Italian Ministry of Health and Civil Protection Department ER -